4833X 15/1000 (Actoplus Met XR 1000 mg / 15 mg)
Generic Name: metformin/pioglitazone
Pill with imprint 4833X 15/1000 is White, Round and has been identified as Actoplus Met XR 1000 mg / 15 mg. It is supplied by Takeda Pharmaceuticals America.
ActoPlus Met XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met XR 1000 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 4833X 15/1000
Actoplus Met XR
- Generic Name
- metformin/pioglitazone
- Imprint
- 4833X 15/1000
- Strength
- 1000 mg / 15 mg
- Color
- White
- Size
- 13.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceuticals America
- National Drug Code (NDC)
- 64764-0510
- Inactive Ingredients
-
candelilla wax,
cellulose acetate,
lactose monohydrate,
magnesium stearate,
polyethylene glycol 400,
polyethylene glycol 8000,
sodium lauryl sulfate,
titanium dioxide,
triacetin,
shellac,
propylene glycol,
ammonia,
ferric oxide red
Note: Inactive ingredients may vary.
More about ActoPlus Met XR (metformin / pioglitazone)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: antidiabetic combinations
- FDA Alerts (3)
Consumer resources
Professional resources
Other Formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.